Ferric citrate 1000 MG Oral Tablet — RxCUI 1594680
RxNorm drug concept · Semantic clinical drug
RxCUI 1594680
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1594680
Official nameFerric citrate 1000 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asferric citrate 1 GM Oral Tablet; ferric citrate (as iron) 210 MG Oral Tablet; ferric citrate 1 GM (iron 210 MG) Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)12,907 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ferric Citrate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Not at all — this is completely expected and one of the most common things people notice when they start ferric citrate. The iron in the medication causes stools to turn dark or ev...
- Why are my stools turning dark or black — is that dangerous?
- You should always take ferric citrate with meals — that's an important part of how it works, especially for controlling phosphorus. The medication binds to phosphate from the food...
- Do I have to take it with food, or can I take it on an empty stomach?
🕸️ Concept Web — How Ferric citrate 1000 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ferric citrate 1000 MG Oral Tablet
RxCUI 1594680 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ferric citrate
1594675IN
-
Ferric citrate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Auryxia
1596018BN
-
Auryxia
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ferric citrate Oral Tablet
1594679SCDF -
Ferric citrate Oral Product
1594677SCDG -
Ferric citrate Pill
1594678SCDG -
Ferric citrate Oral Tablet [Auryxia]
1596020SBDF -
Auryxia Oral Product
1596021SBDG -
Auryxia Pill
1596022SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ferric citrate Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ferric citrate 1000 MG
1594676SCDC -
Ferric citrate 1000 MG Oral Tablet [Auryxia]
1596023SBD -
Ferric citrate 1000 MG [Auryxia]
1596019SBDC
-
Ferric citrate 1000 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ferric citrate 1000 MG
SCDC · 1594676 -
Ferric citrate Oral Tablet
SCDF · 1594679 -
Ferric citrate Oral Product
SCDG · 1594677 -
Ferric citrate Pill
SCDG · 1594678
Brand-Name Concepts
-
Ferric citrate 1000 MG Oral Tablet [Auryxia]
SBD · 1596023 -
Ferric citrate 1000 MG [Auryxia]
SBDC · 1596019 -
Ferric citrate Oral Tablet [Auryxia]
SBDF · 1596020 -
Auryxia Oral Product
SBDG · 1596021 -
Auryxia Pill
SBDG · 1596022 -
Auryxia
BN · 1596018
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 1594680 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-2895-20 | 200 TABLET, FILM COATED in 1 BOTTLE (0378-2895-20) | Ferric Citrate | Mylan Pharmaceuticals Inc. | 2025-03-20 |
| 00480-2996-97 | 200 TABLET, FILM COATED in 1 BOTTLE (0480-2996-97) | Ferric Citrate | Teva Pharmaceuticals, Inc. | 2026-03-11 |
| 59922-0631-01 | 200 TABLET, FILM COATED in 1 BOTTLE (59922-631-01) | Auryxia | Akebia Therapeutics, Inc. | 2014-09-17 |
Observed labelers:
Akebia Therapeutics, Inc. (1) ·
Mylan Pharmaceuticals Inc. (1) ·
Teva Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.